102 related articles for article (PubMed ID: 24732207)
1. Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: highlights from animal studies.
Eisa-Beygi S; Ekker M; Moon TW; Macdonald RL; Wen XY
Reprod Toxicol; 2014 Jul; 46():115-20. PubMed ID: 24732207
[TBL] [Abstract][Full Text] [Related]
2. The 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway regulates developmental cerebral-vascular stability via prenylation-dependent signalling pathway.
Eisa-Beygi S; Hatch G; Noble S; Ekker M; Moon TW
Dev Biol; 2013 Jan; 373(2):258-66. PubMed ID: 23206891
[TBL] [Abstract][Full Text] [Related]
3. Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene.
Ohashi K; Osuga J; Tozawa R; Kitamine T; Yagyu H; Sekiya M; Tomita S; Okazaki H; Tamura Y; Yahagi N; Iizuka Y; Harada K; Gotoda T; Shimano H; Yamada N; Ishibashi S
J Biol Chem; 2003 Oct; 278(44):42936-41. PubMed ID: 12920113
[TBL] [Abstract][Full Text] [Related]
4. A mutation in zebrafish hmgcr1b reveals a role for isoprenoids in vertebrate heart-tube formation.
D'Amico L; Scott IC; Jungblut B; Stainier DY
Curr Biol; 2007 Feb; 17(3):252-9. PubMed ID: 17276918
[TBL] [Abstract][Full Text] [Related]
5. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
Karthik MV; Satya Deepak MV; Shukla P
Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
[TBL] [Abstract][Full Text] [Related]
6. Hmgcr in the corpus allatum controls sexual dimorphism of locomotor activity and body size via the insulin pathway in Drosophila.
Belgacem YH; Martin JR
PLoS One; 2007 Jan; 2(1):e187. PubMed ID: 17264888
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival.
Lacher SM; Bruttger J; Kalt B; Berthelet J; Rajalingam K; Wörtge S; Waisman A
Cell Death Dis; 2017 May; 8(5):e2824. PubMed ID: 28542128
[TBL] [Abstract][Full Text] [Related]
8. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
Buechler RD; Peffley DM
Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase guides migrating primordial germ cells.
Van Doren M; Broihier HT; Moore LA; Lehmann R
Nature; 1998 Dec; 396(6710):466-9. PubMed ID: 9853754
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
11. Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR).
Sharpe LJ; Brown AJ
J Biol Chem; 2013 Jun; 288(26):18707-15. PubMed ID: 23696639
[TBL] [Abstract][Full Text] [Related]
12. [The key enzyme of cholesterol synthesis pathway: HMG-CoA reductase and disease].
Wang W; Tong TJ
Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):5-9. PubMed ID: 12532841
[TBL] [Abstract][Full Text] [Related]
13. Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase.
De Giorgi M; Jarrett KE; Burton JC; Doerfler AM; Hurley A; Li A; Hsu RH; Furgurson M; Patel KR; Han J; Borchers CH; Lagor WR
J Lipid Res; 2020 Dec; 61(12):1675-1686. PubMed ID: 33109681
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
[TBL] [Abstract][Full Text] [Related]
16. Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis.
Choi J; Mouillesseaux K; Wang Z; Fiji HD; Kinderman SS; Otto GW; Geisler R; Kwon O; Chen JN
Development; 2011 Mar; 138(6):1173-81. PubMed ID: 21307094
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
Straka MS; Panini SR
Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death.
Nagashima S; Yagyu H; Ohashi K; Tazoe F; Takahashi M; Ohshiro T; Bayasgalan T; Okada K; Sekiya M; Osuga J; Ishibashi S
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1824-31. PubMed ID: 22701022
[TBL] [Abstract][Full Text] [Related]
20. The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model.
Andrade-Pavón D; Sánchez-Sandoval E; Rosales-Acosta B; Ibarra JA; Tamariz J; Hernández-Rodríguez C; Villa-Tanaca L
Rev Iberoam Micol; 2014; 31(1):81-5. PubMed ID: 24270073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
